VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 487 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2014. The put-call ratio across all filers is 0.91 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $446,634,000 | -69.4% | 4,393,848 | -46.3% | 1.61% | -68.3% |
| Q3 2015 | $1,458,538,000 | +284.2% | 8,176,586 | +378.5% | 5.07% | +314.0% |
| Q2 2015 | $379,597,000 | +65.3% | 1,708,746 | +47.8% | 1.22% | +78.7% |
| Q1 2015 | $229,588,000 | +53.9% | 1,155,927 | +10.9% | 0.68% | +70.4% |
| Q4 2014 | $149,149,000 | +4691.2% | 1,042,191 | +4296.5% | 0.40% | +4925.0% |
| Q3 2014 | $3,113,000 | -46.1% | 23,705 | -48.0% | 0.01% | -50.0% |
| Q2 2014 | $5,771,000 | -71.3% | 45,552 | -70.2% | 0.02% | -69.2% |
| Q1 2014 | $20,114,000 | -30.9% | 152,647 | -38.5% | 0.05% | -26.8% |
| Q4 2013 | $29,096,000 | -2.1% | 248,074 | -12.8% | 0.07% | -9.0% |
| Q3 2013 | $29,709,000 | +288.7% | 284,340 | +219.7% | 0.08% | +290.0% |
| Q2 2013 | $7,644,000 | – | 88,929 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |